|
hosted by the Industry-University-Government Interface (IUGI) Sector
|
|
12/12/2023
|
|
When:
|
Tuesday, December 12, 2023 2:00 -3:00 pm ET
|
|
Where:
|
Online United States
|
|
Contact:
|
webinars@les.org
|
Online registration is closed.
|
|
« Go to Upcoming Event List
|
|
|

Yescarta: A Journey from Development to Licensing hosted by the Industry-University-Government Interface (IUGI) Sector
Tuesday, December 12, 2023 2:00 pm - 3:00 pm Eastern 1:00 pm - 2:00 pm Central 12:00 pm - 1:00 pm Mountain 11:00 am - 12:00 pm Pacific Program: The presentation will address two topics related to licensing efforts of the National Cancer Institute (NCI). The first, a case study on the CAR-T product axicabtagene ciloleucel (sold under the brand name Yescarta®), will cover the development history of this ground-breaking therapy from the NCI technology transfer perspective. The second will be a brief discussion of NCI’s exclusive licensing practices as they concern important technologies in the adoptive cell therapy space. This will touch on how the NCI leverages federal licensing statute (e.g., 37 CFR § 404) to maximize utilization and public benefit of these inventions. Speaker: | Andrew Burke, Senior Technology Transfer Manager, National Cancer Institute
Dr. Andrew Burke is a Senior Technology Transfer Manager for the National Cancer Institute’s (NCI) Technology Transfer Center. He joined the office in July 2013. In his current position, he manages a portfolio of intellectual property and related licenses covering the research of Dr. Steven A. Rosenberg, Chief of Surgery, and the investigators and staff of NCI Surgery Branch. His efforts in this regard have resulted in regional and national awards, including a 2020 and 2018 national citation for “Excellence in Technology Transfer” from the Federal Laboratory Consortium and the 2016 technology transfer “rookie of the year” award for the mid-Atlantic region. Prior to joining NIH technology transfer operations, Andrew was a Cancer Genetics and Signaling Fellow at NCI-Frederick in the lab of Dr. Brad St. Croix. Andrew received his Ph.D. in Cancer Biology from Wake Forest University School of Medicine under the direction of Drs. Frank and Suzy Torti with a dissertation describing the use of multiwalled carbon nanotubes for the photothermal treatment of cancer. He received a B.A. degree in Biology from Pepperdine University. |
LES Members Price: FREE
(LES International Members please contact info@les.org for a code) Non-Members: $69 Want to view this and all LES webinars (recorded and LIVE) for free - Join LES Today! Email Consent: By registering for this event, you permit LES to use your email address to communicate with you regarding LES events and their other services. You will have the ability to unsubscribe from these communications going forward.
|
|
|